Press release: Cell And Gene Therapy Catapult Launches 2021 Clinical Trials Database Report
Commercially sponsored trials now represent nearly 80% of all UK ATMP clinical trials, demonstrating the attractiveness of the UK’s ecosystem and ATTC network to industry. Phase 1 trials increased by 32% in 2021, representing a considerable transition of advanced therapies into first-in-human trials. Report further demonstrates the UK’s leading position as a thriving hub for advanced clinical research.
Find the full Cell and Gene Therapy Catapult 2021 ATMP clinical trials database report here.
Read the Press release here. Published on the 22nd of March 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (3 août 2022). Press release: Cell And Gene Therapy Catapult Launches 2021 Clinical Trials Database Report. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/o624





